MedTrace Logo

AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia

NCT03167294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2017-11-17

No results posted yet for this study

Summary

Single-arm prospective, interventional clinical trial. Results will be compared to a historical control in the treatment of benign prostatic hyperplasia

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

AquaBeam System

Aquablation

Sponsors & Collaborators

  • PROCEPT BioRobotics

    lead INDUSTRY

Principal Investigators

  • Ravindra Sabnis · Chairman, department of Urology Muljibhai Patel Urological Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-14
Primary Completion
2016-06-30
Completion
2017-04-27

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167294 on ClinicalTrials.gov